Abstracts S161
Young Investigator Award IV - Prevention, Epidemiology & Population Science Saturday, 16 May 2015, 08:30–10:00 716 Glycated haemoglobin levels in a chronic ischaemic heart disease primary care cohort of diabetic patients have a prognosis influence, findings of a U shape curve in BARIHD study
Barbanza Investigators, O Ferreiro Uriz1, O Rego Ojea1, F Berrocal De Partearroyo1, A Castro Cives1, I Pazos Del Olmo1, B Capeans Gonzalez1, A Ramos Gonzalez1, R C Rafael Carlos Vidal Perez1, F Otero Ravina1, JR Gonzalez-Juanatey1 1 University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain Topic: Diabetes Purpose: There is scarce data about the influence of diabetes control measured by glycated haemoglobin (HbA1c) outside clinical trials in chronic ischaemic heart disease (CIHD). We assessed the influence of HbA1c levels in the outcomes during the follow up of CIHD cohort in a primary care physicians (PCP) setting Methods: BARIHD was a cross-sectional multicentric study made with the collaboration of 69 PCP. The PCP included during February 2007,patients that fulfil the inclusion criteria: coronary artery disease (CAD) with at least 1 year of follow up since diagnosis, diagnosis clear established (stable angina, unstable angina or myocardial infarction-MI) in a discharge summary from cardiology department. Follow-up was done by clinical review or telephone contact and death or CV events were recorded, as well as the cause of death. Results: 1108p were included, we found 318 diabetic patients (28.7%), they were older (71.1 vs 68.5 years old, p
Young Investigator Award IV - Prevention, Epidemiology & Population Science Saturday, 16 May 2015, 08:30–10:00 716 Glycated haemoglobin levels in a chronic ischaemic heart disease primary care cohort of diabetic patients have a prognosis influence, findings of a U shape curve in BARIHD study
Barbanza Investigators, O Ferreiro Uriz1, O Rego Ojea1, F Berrocal De Partearroyo1, A Castro Cives1, I Pazos Del Olmo1, B Capeans Gonzalez1, A Ramos Gonzalez1, R C Rafael Carlos Vidal Perez1, F Otero Ravina1, JR Gonzalez-Juanatey1 1 University Clinical Hospital of Santiago de Compostela, Santiago de Compostela, Spain Topic: Diabetes Purpose: There is scarce data about the influence of diabetes control measured by glycated haemoglobin (HbA1c) outside clinical trials in chronic ischaemic heart disease (CIHD). We assessed the influence of HbA1c levels in the outcomes during the follow up of CIHD cohort in a primary care physicians (PCP) setting Methods: BARIHD was a cross-sectional multicentric study made with the collaboration of 69 PCP. The PCP included during February 2007,patients that fulfil the inclusion criteria: coronary artery disease (CAD) with at least 1 year of follow up since diagnosis, diagnosis clear established (stable angina, unstable angina or myocardial infarction-MI) in a discharge summary from cardiology department. Follow-up was done by clinical review or telephone contact and death or CV events were recorded, as well as the cause of death. Results: 1108p were included, we found 318 diabetic patients (28.7%), they were older (71.1 vs 68.5 years old, p
